H & M Hennes & Mauritz AB (publ) (OTCMKTS:HNNMY – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $2.94 and traded as low as $2.66. H & M Hennes & Mauritz AB (publ) shares last traded at $2.68, with a volume of 24,280 shares changing hands.
Analyst Ratings Changes
Several equities analysts have issued reports on HNNMY shares. Royal Bank of Canada cut shares of H & M Hennes & Mauritz AB (publ) from a “moderate buy” rating to a “hold” rating in a research note on Tuesday, November 26th. Redburn Atlantic lowered shares of H & M Hennes & Mauritz AB (publ) from a “hold” rating to a “strong sell” rating in a research note on Thursday, October 31st. One research analyst has rated the stock with a sell rating, one has given a hold rating, two have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy”.
Read Our Latest Stock Analysis on HNNMY
H & M Hennes & Mauritz AB (publ) Stock Up 1.5 %
H & M Hennes & Mauritz AB (publ) (OTCMKTS:HNNMY – Get Free Report) last issued its earnings results on Wednesday, January 29th. The company reported $0.04 EPS for the quarter, topping the consensus estimate of $0.03 by $0.01. H & M Hennes & Mauritz AB (publ) had a net margin of 4.93% and a return on equity of 26.25%. As a group, sell-side analysts expect that H & M Hennes & Mauritz AB will post 0.15 EPS for the current fiscal year.
About H & M Hennes & Mauritz AB (publ)
H & M Hennes & Mauritz AB (publ) provides clothing, accessories, footwear, cosmetics, home textiles, and homeware for women, men, and children worldwide. It offers sportswear, shoes, bags, beauty products, activewear, jeans, and ready-to-wear; and interior products, including bed linens, dinnerware, textiles, furniture, and lighting.
See Also
- Five stocks we like better than H & M Hennes & Mauritz AB (publ)
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Merck: 4 No-Brainer Reasons to Buy This Dip
- How to Most Effectively Use the MarketBeat Earnings Screener
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- How to Invest in Biotech Stocks
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for H & M Hennes & Mauritz AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H & M Hennes & Mauritz AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.